In recent research, with the overexpression of the Wnt/β-catenin pathway inducing tumor progression in CRC, a key transcription factor, FOXO3a has been reported as an accelerator overexpressing its target genes through binding with β-catenin. The gene discussed is FOXO3; the disease is colorectal carcinoma.